Life Extension
LE Magazine September 2006
image

Broad-spectrum Cardiac Protection with Fish Oil


Lower Triglycerides, Reduce Arrhythmia, and Slow Plaque Growth with Omega-3s By William Davis, MD

In this article, I will share with you the extraordinary success story of Stacy—a patient who came to me with a cholesterol level at a whopping 594 mg/dL and triglycerides that were off the chart at 2,893 mg/dL—and her amazing turnaround in blood test results achieved through the use of fish oil.

A Patient at Risk: Stacy’s Frightening Blood Test Results

Stacy, a 40-year-old physical therapist, was terrified to learn the results of her most recent cholesterol tests: dangerously elevated total cholesterol of 594 mg/dL and sky-high triglycerides of 2,893 mg/dL. Because these values were so high, her levels of dangerous low-density lipoprotein (LDL) and beneficial high-density lipoprotein (HDL) could not be determined.

When I met with Stacy, she was in a panic. In tears, she declared, “I don’t understand it. I take good care of myself. I don’t eat fatty foods, I exercise, I don’t do anything wrong!”

She was correct. Her frightening lipid levels were not due to anything “bad” she had done, but instead were a combination of genetics (“familial hypertriglyceridemia”) and modest dietary excesses. However, these levels of triglycerides and cholesterol posed risks for liver disease and pancreatic disease (pancreatitis), as well as heightened long-term risk for heart disease and stroke. Stacy also showed some features of the metabolic syndrome: her blood sugar was slightly elevated at 114 mg/dL, her blood pressure was high at 140/88 mmHg, and she showed an excess of abdominal fat, standing 5 feet, 5 inches tall and weighing 160 pounds.

Fish Oil Lowers Triglycerides

Dangerously high levels of triglycerides have become more common as Americans develop metabolic syndrome. Elevated triglycerides greatly increase risk for heart disease. Omega-3s can significantly reduce triglyceride levels and help correct other cardiac risk factors that accompany metabolic syndrome.1-3 In fact, omega-3 fatty acids derived from fish oils are now available in the form of a prescription drug called Omacor®, which has been approved specifically for the treatment of elevated triglycerides.4 (For more on this subject, see this month’s “As We See It.”)

Omega-3s Inhibit Inflammatory Compounds

Hidden, imperceptible inflammation is now recognized for its role in triggering a chain of events leading to heart disease and other illnesses. Omega-3 fatty acids suppress multiple steps in this inflammatory process, inhibiting the production of inflammatory cytokines and prostaglandins. Furthermore, omega-3 fats boost production of anti-inflammatory compounds. These anti-inflammatory effects may have important implications for fighting heart disease and numerous other disease processes associated with excessive inflammation.10-16

An important marker of inflammation in the body known as C-reactive protein (CRP) is associated with an increased risk of cardiovascular disease. Measuring high-sensitivity CRP is an emerging method of detecting hidden inflammation and its associated cardiovascular disease risk.17 Some scientists have observed that people who consume a greater amount of omega-3 fatty acids demonstrate lower levels of this cardiovascular risk factor, suggesting that omega-3 supplementation might help prevent cardiovascular disease by fighting inflammation.18

Fish Oils Rich in Omega-3s Fight After-Meal Surges in Blood Fats

An exciting area of research focuses on post-meal elevated blood fat (lipid) levels, known as post-prandial hyperlipidemia. This is essentially the flood of fat in the blood that occurs following a meal, which scientists suspect may be a potent contributor to atherosclerosis (and acute heart attack).5 A unique effect of omega-3 fatty acids (found in cold-water fish oil) is to accelerate the clearance of fat-containing particles from the blood following meals. Fish oil’s profound fat-clearing ability has important implications for cardiovascular disease prevention.6

Omega-3s Slow Plaque Growth and Prevent Blood Clots

Heart attacks can result from unstable atherosclerotic plaque. The rupturing of unstable plaque inside a coronary artery has been compared to a kernel of popcorn bursting open and occluding (blocking) the flow of blood through the vessel. These kinds of heart attacks can occur suddenly, without typical symptoms such as angina and shortness of breath. Omega-3s from fish oil may help to modify the structure of atherosclerotic plaque in ways that make it less dangerous. In fact, studies show that omega-3s can slow the rate of atherosclerotic plaque growth.7,8

Fish Oils Help Improve Endothelial Function

Cutting-edge scientists know that one of the instigating factors in cardiovascular disease is endothelial dysfunction, in which the delicate cells lining the blood vessels cannot dilate in response to increased demand for blood flow.

Fish oils are rich in omega-3 fatty acids. A recent study found that greater intake of omega-3s was clearly correlated with lower levels of blood markers associated with dangerous endothelial dysfunction.18 A past study showed that fish oil rich in omega-3 fatty acids contributes to healthy vascular function by increasing the production of an important blood vessel-dilating substance in the endothelial cells.7

A fascinating study showed that omega-3 supplementation actually changed the composition of unstable atherosclerotic plaque, making it less likely to rupture and thus less dangerous. Subjects who had severe carotid plaque and were scheduled to have it surgically removed received either fish oil or sunflower oil prior to surgery. When the plaque was removed at surgery and examined, researchers found that those who took fish oil had less plaque inflammation as well as more stable plaque. By contrast, those who took sunflower oil had more unstable, rupture-prone plaque.9

The omega-3 fatty acids found in fish oil also help reduce certain proteins that promote abnormal blood clotting and inhibit platelet aggregation, two effects that reduce the likelihood of clot formation on active, ruptured coronary plaque that could result in a heart attack.19

Although the blood-thinning effect of fish oil is modest, people who suffer from an abnormal bleeding tendency or use blood-thinning drugs such as Coumadin® should consult a physician before taking fish oil. The best way of determining if one is taking the optimal dose of Coumadin® and fish oil is to have a doctor perform a template bleeding time test. (Details about this test can be found in the Thrombosis Prevention chapter of the Disease Prevention and Treatment book. )

Omega-3s Normalize Heart Rhythm, Prevent Sudden Cardiac Death

One of the most dramatic benefits of fish oil is its ability to prevent sudden death, particularly sudden cardiac death. Scientists believe that omega-3 fatty acids from cold-water fish may help prevent these sudden deaths by reducing potentially fatal abnormal heart rhythms, or arrhythmias.

To investigate the life-saving benefits of fish oil, scientists studied more than 2,000 men who had previously suffered a heart attack. Some of the men were advised to regularly consume cold-water fish, while others did not receive this dietary advice. After two years, the difference in mortality between the two groups was dramatic: men who ate fish twice a week had a 29% lower rate of death than those who did not. Scientists believe that fish oil helped prevent death by suppressing dangerous, abnormal heart rhythms in these men with a history of heart muscle damage.20

Fish Oils and Omega-3s Counter Dangerous Metabolic Syndrome

Fish oils rich in omega-3 fatty acids provide special benefits for people with metabolic syndrome, an increasingly prevalent condition associated with a greatly elevated risk for heart disease and diabetes. Approximately 47 million US adults are affected by this condition, which is characterized by low levels of beneficial high-density lipoprotein (HDL), increased triglycerides, high blood pressure, insulin resistance, and elevated C-reactive protein. Omega-3 supplementation provides important cardiovascular benefits in people with metabolic syndrome by improving both blood pressure and insulin sensitivity.1,2

Another important study showed that people dying from sudden cardiac death had lower blood levels of omega-3 fatty acids than those who did not. Eating one or more servings of fish each week produced important heart-protective benefits, reducing the risk of sudden cardiac death by a stunning 52%.21

A major clinical study provides more good news about fish oil. In this large study of more than 11,000 adults, those who consumed 1000 mg of EPA and DHA daily had a 30% reduced rate of cardiovascular death and a 20% lower rate of sudden death. Moreover, the protective benefits of fish oil were apparent after only a few months of supplementation.22

Fish oil’s ability to promote healthy heart rhythms is so impressive that some cardiologists now recommend it for their patients who have the implanted devices known as defibrillators to prevent life-threatening heart arrythmias.23,24 In this patient population, the goal of supplementation with omega-3 fatty acids is to reduce rhythm instability.

Fish oil is particularly effective in fighting the common but worrisome heart arrhythmia known as atrial fibrillation. This is especially important, as atrial fibrillation increases the risk of stroke. One study showed that fish oil effectively reduced the incidence of atrial fibrillation by a remarkable 54% in people recovering from bypass surgery.25

Scientists have observed that people who suffer heart arrhythmias often demonstrate low levels of omega-3 fatty acids in their blood, further suggesting that omega-3 supplementation is clinically useful for promoting healthy heart rhythm.24

Continued on Page 2 of 2


LE Magazine September 2006
image

Broad-spectrum Cardiac Protection with Fish Oil


Lower Triglycerides, Reduce Arrhythmia, and Slow Plaque Growth with Omega-3s By William Davis, MD

Fish Oil: Best Source of Omega-3s

Omega-3 Dosing Strategies

In order to help my patients reduce their cardiovascular disease risk factors, I suggest 1200 mg per day of omega-3 fatty acids (EPA + DHA). In my clinical practice, I have noted that this dose yields measurable improvements in cardiovascular risk factors. Omega-3 doses of 1800 mg per day may provide even greater benefits, and this is the dose we commonly use in our program to help reverse heart disease. To address elevated triglyceride levels, my clinic often recommends 1200-3000 mg per day of omega-3 fatty acids.

Fish oil and cold-water fish are the most concentrated sources of EPA and DHA. A secondary, much less concentrated source is alpha-linolenic acid from flaxseed, flaxseed oil, walnuts, and canola oil. However, only a small portion of ingested alpha-linolenic acid is converted into active EPA or DHA.26 Although linolenic acid may provide unique health benefits of its own, fish oil remains by far the most abundant source of heart-healthy omega-3s.

Success Story: Remarkable Changes in Stacy’s Blood Test Results

I advised Stacy to take 2700 mg of omega-3 fatty acids every day. She chose a low-potency, low-cost fish oil that required nine capsules to be consumed each day. She accomplished this by taking three capsules three times per day with meals. Stacy required more than most people, due to her unusually high triglycerides. Within several weeks, however, she was out of immediate danger: the omega-3s caused her triglycerides to plummet to 344 mg/dL.

Over the next few months, we counseled Stacy on reducing her intake of processed carbohydrates like crackers, pretzels, breakfast cereals, and other wheat-containing products. We also advised her to avoid high-fructose corn syrup, a common food additive that contributes to elevated triglyceride levels, and to reduce her weight by about 20 pounds. Stacy accomplished all this. Her most recent blood panel showed total cholesterol of 165 mg/dL, triglycerides of 144 mg/dL, HDL of 70 mg/dL, and LDL of 66 mg/dL.

Although an extreme case, Stacy’s experience demonstrates that omega-3 fatty acids such as EPA and DHA can form the foundation of a powerful strategy to dramatically reduce dangerously high blood lipid levels without the use of prescription drugs.

No prescription medication can provide the profound results that Stacy obtained from the omega-3 fatty acids in fish oil. If we did not have fish oil at our disposal, she would have required at least three additional prescription medications and yet would have achieved less than 50% of the benefit. 

If I were forced to choose one supplement to prevent heart disease, I would choose omega-3 fatty acids from fish oil without hesitation. When you witness the hidden genetic and acquired causes of heart disease that we identify in our heart disease-reversal program, you develop new respect for the power of fish oil. In many instances, fish oil not only corrects but eliminates these patterns. It has been responsible for much of our success.

Conclusion

Omega-3 polyunsaturated fatty acids such as EPA and DHA protect cardiovascular health in myriad ways, combating several critically important cardiovascular risk factors.

 

“In terms of its potential impact on health in the Western world, the ‘omega-3’ story may some day be viewed as one of the most important in the history of modern nutritional science.”

Dr. William Harris
St. Luke’s Mid-America Heart Institute
University of Missouri-Kansas City

Research clearly demonstrates that these crucial fats help prevent deadly heart arrhythmias and sudden cardiac death. Omega-3s show efficacy in fighting disease-provoking inflammatory processes and averting the insidious phenomenon of endothelial dysfunction. Omega-3 fatty acids have potent triglyceride-reducing effects and provide the additional benefit of reducing the after-meal flood of fat in the bloodstream, an emerging risk factor for cardiovascular disease. Furthermore, omega-3 fatty acids help stabilize dangerous atherosclerotic plaque and prevent dangerous blood clots.

These multifaceted heart-protective effects of omega-3 fatty acids make fish oil part of the foundation of a nutritional strategy to guard against cardiovascular disease and stroke.

Dr. William Davis is an author, lecturer, and cardiologist practicing in Milwaukee, WI. He is founder of Track your Plaque, a heart disease-prevention program that shows how to use CT heart scans to control coronary plaque. He can be contacted through www.trackyourplaque.com.

Continued on Omega-3 Fatty Acids Show Promise in Fighting Deadly Cancers

References

1. Menuet R, Lavie CJ, Milani RV. Importance and management of dyslipidemia in the metabolic syndrome. Am J Med Sci. 2005 Dec;330(6):295-302.

2. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health. 2005 Sep;64(4):396-408.

3. Balk EM, Lichtenstein Ah, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis. 2006 Mar 9; [Epub ahead of print]

4. Harris WS, Ginsberg HN, Arunkul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):385-91.

5. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994 Mar;106(1):83–97.

6. Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n–3 fatty acids. Am J Clin Nutr. 2000 Apr;71(4):914–20.

7. Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr. 1997 Oct;66(4 Suppl):1020S-31S.

8. Abeywardena MY, Head RJ. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res. 2001 Dec;52(3):361-71.

9. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet. 2003 Feb 8;361(9356):477–85.

10. Watkins BA, Li Y, Lippman HE, Seifert MF. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med. 2001 Jun;226(6):485–97.

11. Ciubotaru I, Lee YS, Wander RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem. 2003 Sep;14(9):513–21.

12. Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003 Jan;23(1):27-36.

13. Solomon DH. Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum. 2005 Jul;52(7):1968–78.

14. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 2005 Jun 11;330(7504):1366.

15. Cleland LG, James MJ. Marine oils for anti-inflammatory effect—time to take stock. J Rheumatol. 2006 Feb;33(2):207–9.

16. Leaf A. On the reanalysis of the GISSI-Prevenzione. Circulation. 2002 Apr 23;105(16):1874–5.

17. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004 Aug;29(8):439-93.

18. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr. 2004 Jul;134(7):1806-11.

19. Vanschoonbeek K, Feijge MAH, Paquay M, et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol. 2004 Sept;24(9):1734–40.

20. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989 Sept 30;2(8666):757-61.

21. Albert CM, Hennekens CH, O’Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998 Jan 7;279(1):23-8.

22. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999 Aug 7;354(9177):447-55.

23. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005 Nov 1;112(18):2762–8.

24. Christensen JH, Riahi S, Schmidt EB, et al. n-3 fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace. 2005 Jul;7(4):338–44.

25. Calo L, Bianconi L, Colivichi F, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005 May 17;45(10):1723-8.

26. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005 Sep-Oct;45(5):581-97.

All Contents Copyright © 1995-2009 Life Extension Foundation All rights reserved.

Life Extension

These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.